Trial intelligence / Profile preview

Lucrin Depot vs OCP vs Natural Cycle for FET Scheduling

NCT02238431Withdrawn

Sponsor
Antalya IVF
Start
Dec 2014
Primary completion
May 2016
Modality
Peptides, Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of leuprolide in infertility (3 arms), sponsored by Antalya IVF. Primary endpoint: Cycle cancellation. Planned start Dec 2014; status: withdrawn.

02

Drugs

leuprolide
03

Conditions

infertility

Beyond the preview

Go deeper on NCT02238431.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02238431.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call